UBS AG Trims Nustar GP Holdings, LLC (NSH) Target Price to $21.00
Nustar GP Holdings, LLC (NYSE:NSH) had its price target reduced by UBS AG from $33.00 to $21.00 in a research report released on Wednesday morning, www.benzinga.com reports. UBS AG currently has a buy rating on the pipeline company’s stock.
Several other equities research analysts have also weighed in on the company. BidaskClub upgraded Nustar GP Holdings from a strong sell rating to a sell rating in a report on Tuesday, June 27th. Zacks Investment Research lowered Nustar GP Holdings from a hold rating to a sell rating in a report on Thursday, September 28th. Credit Suisse Group set a $28.00 target price on Nustar GP Holdings and gave the stock a hold rating in a report on Sunday, July 30th. Citigroup Inc. reduced their target price on Nustar GP Holdings from $30.00 to $24.00 and set a buy rating for the company in a report on Tuesday, October 10th. Finally, Wells Fargo & Company lowered Nustar GP Holdings from an outperform rating to a market perform rating in a report on Monday, July 17th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and two have given a buy rating to the company’s stock. Nustar GP Holdings has a consensus rating of Hold and a consensus price target of $25.50.
Nustar GP Holdings (NSH) traded down 2.45% during mid-day trading on Wednesday, hitting $17.95. 135,842 shares of the stock were exchanged. Nustar GP Holdings has a 52 week low of $17.80 and a 52 week high of $31.50. The company has a 50 day moving average price of $21.15 and a 200 day moving average price of $23.67. The stock has a market cap of $770.97 million, a price-to-earnings ratio of 8.42 and a beta of 1.19.
Nustar GP Holdings (NYSE:NSH) last posted its earnings results on Friday, July 28th. The pipeline company reported $0.56 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.35 by $0.21. Nustar GP Holdings had a return on equity of 25.68% and a net margin of 176.62%. The firm had revenue of $10.96 million during the quarter, compared to analyst estimates of $16.22 million. Analysts expect that Nustar GP Holdings will post $2.29 EPS for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “UBS AG Trims Nustar GP Holdings, LLC (NSH) Target Price to $21.00” was originally reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this piece of content on another website, it was illegally copied and republished in violation of United States & international copyright and trademark legislation. The original version of this piece of content can be read at https://www.thecerbatgem.com/2017/10/21/ubs-ag-trims-nustar-gp-holdings-llc-nsh-target-price-to-21-00.html.
The firm also recently declared a quarterly dividend, which will be paid on Thursday, November 16th. Stockholders of record on Thursday, November 9th will be issued a dividend of $0.545 per share. The ex-dividend date is Wednesday, November 8th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 12.14%. Nustar GP Holdings’s dividend payout ratio (DPR) is presently 102.83%.
In other Nustar GP Holdings news, Director William E. Greehey purchased 6,423 shares of the business’s stock in a transaction dated Monday, August 7th. The stock was bought at an average cost of $22.01 per share, for a total transaction of $141,370.23. Following the completion of the acquisition, the director now directly owns 8,646,280 shares in the company, valued at $190,304,622.80. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director William E. Greehey purchased 41,235 shares of the business’s stock in a transaction dated Thursday, August 31st. The shares were acquired at an average price of $21.09 per share, with a total value of $869,646.15. Following the completion of the acquisition, the director now owns 8,762,396 shares of the company’s stock, valued at $184,798,931.64. The disclosure for this purchase can be found here. Over the last quarter, insiders have bought 173,086 shares of company stock valued at $3,715,871. Corporate insiders own 21.39% of the company’s stock.
Hedge funds have recently modified their holdings of the company. Trent Capital Management Inc. NC acquired a new position in shares of Nustar GP Holdings during the second quarter worth approximately $201,000. Stifel Financial Corp acquired a new position in shares of Nustar GP Holdings during the first quarter worth approximately $206,000. Proficio Capital Partners LLC lifted its holdings in shares of Nustar GP Holdings by 11.0% during the second quarter. Proficio Capital Partners LLC now owns 9,345 shares of the pipeline company’s stock worth $214,000 after buying an additional 925 shares during the last quarter. Alliancebernstein L.P. lifted its holdings in shares of Nustar GP Holdings by 5.9% during the second quarter. Alliancebernstein L.P. now owns 8,841 shares of the pipeline company’s stock worth $216,000 after buying an additional 495 shares during the last quarter. Finally, Arrowstreet Capital Limited Partnership acquired a new position in shares of Nustar GP Holdings during the second quarter worth approximately $237,000. Institutional investors own 55.59% of the company’s stock.
About Nustar GP Holdings
NuStar GP Holdings, LLC holds interests in NuStar Energy L.P. (NuStar Energy). NuStar Energy is engaged in the transportation of petroleum products and anhydrous ammonia, the terminalling and storage of petroleum products and the marketing of petroleum products. NuStar Energy has terminal and storage facilities in the United States, Canada, Mexico, the Netherlands, including St.
Receive News & Stock Ratings for Nustar GP Holdings LLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nustar GP Holdings LLC and related stocks with our FREE daily email newsletter.